Therapeutic equivalence? [Design Issues]

posted by bjkim97  – Korea / Seoul, 2011-02-23 12:06 (5191 d 20:52 ago) – Posting: # 6663
Views: 6,059

Dear Dan

I understand your opinion. Anti-Cancer is not all cytotoxic. I agree with your opinion

You say about the imatinib that "No problem"
Then if so, did you think the tests are performed.

Please tell me studying about the imatinib of healthy volunteer.
Safety, AE (adverse event), specific issue eg.

Your advice is very helpful to me!

Kind regard
BJ

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
175 visitors (0 registered, 175 guests [including 2 identified bots]).
Forum time: 09:58 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5